Inflammation-Related Gene Polymorphisms and Colorectal Adenoma
Open Access
- 1 June 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (6) , 1126-1131
- https://doi.org/10.1158/1055-9965.epi-06-0042
Abstract
Chronic inflammation has been reported to be a risk factor for colorectal neoplasia. The propensity to mount an inflammatory response is modified by germ line variation in cytokine and other inflammation-related genes. We hypothesized that a proinflammatory genotype would be positively associated with colorectal adenoma, a precursor of colorectal cancer. We investigated the association of colorectal adenoma with 19 single nucleotide polymorphisms in a range of important proinflammatory (IL1B, IL6, IL8, TNF, and LTA) and anti-inflammatory (IL4, IL10, and IL13) cytokines and other inflammation-related genes (PTGS2 and PPARG) in a case-control study of risk factors for colorectal polyps in which all participants (ages 18-74 years) had undergone colonoscopy or sigmoidoscopy. The study sample comprised 244 cases of colorectal adenoma and 231 polyp-free controls. Compared with being homozygous for the common allele, heterozygosity at the IL1B −31 (C>T) locus was associated with an odds ratio (OR) for colorectal adenoma of 1.8 [95% confidence interval (95% CI), 1.2-2.9]. Homozygous carriers of the IL8 −251-A allele were at 2.7-fold increased risk of adenoma (95% CI, 1.5-4.9) compared with homozygosity for the common T allele, whereas carriage of at least one IL8 −251-A allele conferred a 1.5 increased odds of disease (95% CI, 1.0-2.4). Among non–nonsteroidal anti-inflammatory drug users, there was a statistically significant association between the IL10 −819-T/T genotype and adenoma compared with the common IL10 −819-C/C genotype (OR, 3.9; 95% CI, 1.1-13.6), which was not evident among nonsteroidal anti-inflammatory drug users (OR, 0.7; 95% CI, 0.3-1.5; Pinteraction = 0.01). These exploratory data provide evidence that polymorphic variation in genes that regulate inflammation could alter risk for colorectal adenoma. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1126–31)Keywords
This publication has 32 references indexed in Scilit:
- Dietary Benzo[a]Pyrene Intake and Risk of Colorectal AdenomaCancer Epidemiology, Biomarkers & Prevention, 2005
- The Role of Cytokine Gene Polymorphisms in Colorectal Cancer and Their Interaction with Aspirin Use in the Northeast of ScotlandCancer Epidemiology, Biomarkers & Prevention, 2005
- PTGS2 (COX-2) −765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory DrugsCancer Epidemiology, Biomarkers & Prevention, 2005
- The PPAR Pro12Ala polymorphism and risk for incident sporadic colorectal adenomasCarcinogenesis: Integrative Cancer Research, 2004
- Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapyThe FASEB Journal, 2003
- Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphismGenes & Immunity, 2002
- Common Promoter Variant in Cyclooxygenase-2 Represses Gene ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's diseaseTrends in Molecular Medicine, 2001
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Polymorphic haplotypes of the interleukin-10 5? flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritisArthritis & Rheumatism, 1999